» Articles » PMID: 941073

The Augmentive Use of Methyl Methacrylate in the Management of Pathologic Fractures

Overview
Date 1976 Aug 1
PMID 941073
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Methyl methacrylate is a useful adjunct to obtain secure internal fixation in the treatment of comminuted pathologic fractures. This method was used in 73 patients with 81 pathologic fractures of whom only four failed to regain function in the extremity which was operated upon. While it is probable that methyl methacrylate may have an adverse effect on fracture healing, the fixation achieved when applied to only one surface appears adequate and was observed to last for as long as nine years. The use of methyl methacrylate to augment internal fixation of pathologic fractures offers the patient a better chance to return to normal activities than any of the methods that are in use to date.

Citing Articles

Replacement of epiphyseal bone with methylmethacrylate: its effect on articular cartilage.

Manley P, McKeown D, Schatzker J, Palmer N, Carman S Arch Orthop Trauma Surg (1978). 1982; 100(1):3-10.

PMID: 7125872 DOI: 10.1007/BF00381536.


Pathological fractures due to bone metastases.

Br Med J (Clin Res Ed). 1981; 283(6294):748.

PMID: 6791732 PMC: 1506872. DOI: 10.1136/bmj.283.6294.748.


[Functional results following conservative and surgical therapy of pathologic fractures in malignant diseases].

Friedl W, Ruf W, Krebs H Langenbecks Arch Chir. 1986; 368(3):185-96.

PMID: 3807500 DOI: 10.1007/BF01261235.